2012
DOI: 10.1016/j.cca.2012.08.010
|View full text |Cite
|
Sign up to set email alerts
|

Probing gender-specific lipid metabolites and diagnostic biomarkers for lung cancer using Fourier transform ion cyclotron resonance mass spectrometry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
46
0
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 72 publications
(52 citation statements)
references
References 42 publications
5
46
0
1
Order By: Relevance
“…5). LPC acts as a bioactive mediator in wound healing and inflammation (21), but also has a role in the progression of OVC (22) and lung cancer (23). LPC has many subtypes, and each subtype has a different length of carbon chain.…”
Section: Discussionmentioning
confidence: 99%
“…5). LPC acts as a bioactive mediator in wound healing and inflammation (21), but also has a role in the progression of OVC (22) and lung cancer (23). LPC has many subtypes, and each subtype has a different length of carbon chain.…”
Section: Discussionmentioning
confidence: 99%
“…In particular, this differential metabolite distribution mainly concerned PL species, such as SM 16:0/1, LPC 18:1, LPC 20:4, LPC 20:3, and LPC 22:6; these lipids were associated with lung cancer progression. Authors concluded that serum LPCs could be applied to lung cancer to differentiate patients and healthy subjects and to detect tumors early [48]. Several other pieces of evidence supported the hypothesis that altered lipid compositions can differentiate normal epithelium from tumor.…”
Section: Lipidomics In Cancer Researchmentioning
confidence: 99%
“…The analysis of PLs in cancer cells, tissues, and biofluids is a novel approach and displays growing interest to develop candidate biomarkers of various cancers. Alterations in PL profiles have been associated with cancer diagnosis and treatment (Wenk, 2005;Hammad et al, 2009;Thomas et al, 2010) and specific lipids might be involved in the onset and evolution of cancer (Xiao et al, 2000;Oremek, Sapoutzis, & Lorenz, 2002;Sutphen et al, 2004;Shimma et al, 2007;Dill et al, 2009Dill et al, , 2010Dill et al, , 2011Kim et al, 2009Kim et al, , 2013Min, Kong, & Moon, 2010Jeong et al, 2011;Kang et al, 2011;Liu, Cooks, & Ouyang, 2011Park et al, 2011;Patterson et al, 2011;Doria et al, 2012;Guo et al, 2012;Ishikawa et al, 2012;Lee et al, 2012;Ide et al, 2013;Kurabe et al, 2013;Liao et al, 2013;Xu et al, 2013;Jones et al, 2014;Mirnezami et al, 2014;Patel et al, 2014). Biomarker detection and evaluation based on MS methods is so far well-established in cancer proteomics, but it also has a potential importance in cancer lipidomics.…”
Section: Pls In Various Cancersmentioning
confidence: 99%